DNTH

DIANTHUS THERAPEUTICS INC

DNTH·252828108·US·Common Stock·Healthcare - Biotechnology-Activist

DNTH (DIANTHUS THERAPEUTICS INC) is held by 129 institutional investors as of Q1 2026. Largest holders: FMR LLC ($651.9M), BlackRock, Inc. ($266.5M), RA CAPITAL MANAGEMENT, L.P. ($219.2M). Net institutional sentiment: Bullish.

129
Holders
Avg rating(24 Elite)
$3.4B
Total Value
76% (135)
Fund Consensus
102 buying - 32 selling
DNTHSmart Money Verdict
View all
Held by 129 funds
24 elite
Who's Trading
InsiderSRSavitz RyanSell $1.0MJul 9, 2026
InsiderSRSavitz RyanSell $1.6MJul 9, 2026
InsiderSRSavitz RyanSell $568KJul 9, 2026
InsiderVMVeness Adam MSell $1.3MJun 17, 2026
InsiderVMVeness Adam MSell $1.1MJun 17, 2026
InsiderRSRandhawa SimratSell $487KJun 1, 2026
InsiderRSRandhawa SimratSell $1.5MJun 1, 2026
InsiderRSRandhawa SimratSell $380KJun 1, 2026
ActivistSISirenia Capital Management LP5.3%May 15, 2026
ActivistWellington Management Group LLPWellington Management Group LLP4.8%May 15, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.8M(+20.8%)$651.9M0.0%+207.30%
38
Increased
3.2M(+65.8%)$266.5M0.0%+153.67%
45
Increased
2.6M(+62.0%)$219.2M2.3%+159.81%
76
Increased
2.6M(+3.7%)$217.8M0.0%+145.75%
32
New
2M$170.5M0.0%+76.21%
42
Increased
1.6M(+50.7%)$135.2M0.0%+162.58%
42
Decreased
1.4M(-7.2%)$117.4M0.0%+184.53%
0
Increased
1.2M(+3372.6%)$97.5M0.4%+77.67%
58
Increased
1.1M(+86.2%)$96.3M0.0%+106.59%
47
Increased
1.1M(+7.1%)$90.3M0.3%+138.42%
38
Increased
968,182(+109.2%)$81.2M0.0%+104.03%
48
Increased
916,211(+35.4%)$76.9M0.0%+171.18%
39
Increased
852,164(+7.9%)$71.5M0.4%+378.54%
38
New
836,000$70.2M0.4%+76.21%
49
Increased
781,282(+28.8%)$65.6M0.0%+139.86%
37
Decreased
643,599(-44.8%)$54M0.1%+262.12%
0
Decreased
548,010(-5.0%)$46M0.0%+201.14%
0
New
485,136$40.7M0.0%+76.21%
40
New
474,085$39.8M0.1%+76.21%
40
Increased
926,071(+11.0%)$38.2M0.0%+244.00%
32

Showing 1-20 of 135

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used